Cargando…
Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases
BACKGROUND: Acute exacerbation (AE) of systemic autoimmune disease-related interstitial lung diseases (SAID-ILD) is less common than AE of idiopathic pulmonary fibrosis (IPF) and the details of AE-SAID-ILD have not been elucidated, but the prognosis is similarly devastating. This study was undertake...
Autores principales: | Enomoto, Noriyuki, Naoi, Hyogo, Mochizuka, Yasutaka, Isayama, Takuya, Tanaka, Yuko, Fukada, Atsuki, Aono, Yuya, Katsumata, Mineo, Yasui, Hideki, Mori, Kazutaka, Karayama, Masato, Hozumi, Hironao, Suzuki, Yuzo, Furuhashi, Kazuki, Fujisawa, Tomoyuki, Inui, Naoki, Nakamura, Yutaro, Suda, Takafumi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608932/ https://www.ncbi.nlm.nih.gov/pubmed/36289542 http://dx.doi.org/10.1186/s12890-022-02197-3 |
Ejemplares similares
-
Acute exacerbation of unclassifiable idiopathic interstitial
pneumonia: comparison with idiopathic pulmonary fibrosis
por: Enomoto, Noriyuki, et al.
Publicado: (2020) -
Trimethoprim-sulfamethoxazole induced eosinophilic pneumonia: A case report
por: Mochizuka, Yasutaka, et al.
Publicado: (2022) -
Transient leukocytopenia following combination therapy for COVID-19
por: Tsuchiya, Kazuo, et al.
Publicado: (2022) -
Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosis
por: Suzuki, Yuzo, et al.
Publicado: (2021) -
Switching antifibrotics in patients with idiopathic pulmonary fibrosis: a multi-center retrospective cohort study
por: Suzuki, Yuzo, et al.
Publicado: (2021)